CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-08 | Ber Gerard Director | Shares withheld for taxes | −327 | $94.82 | $31K | 37,023 |
| 2023-04-17 | Blanchfield Paul See Remarks | Grant or award | +8,464 | 95,028 | ||
| 2023-04-17 | Blanchfield Paul See Remarks | Grant or award · Stock Option (right to buy) | +5,025 | 5,025 | ||
| 2023-04-17 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −386 | $88.67 | $34K | 61,904 |
| 2023-04-17 | Niedzwiecki Daniel See Remarks | Grant or award | +3,301 | 78,171 | ||
| 2023-04-17 | Niedzwiecki Daniel See Remarks | Grant or award · Stock Option (right to buy) | +1,960 | 1,960 | ||
| 2023-04-17 | Montagut Etienne Chief Business Officer | Sale 10b5-1 | −2,118 | $88.67 | $188K | 67,254 |
| 2023-04-03 | Montagut Etienne Chief Business Officer | Sale 10b5-1 | −3,684 | $82.09 | $302K | 69,372 |
| 2023-03-27 | MARKISON BRIAN A Director | Sale | −13,290 | $81.13 | $1.1M | 19,318 |
| 2023-03-27 | Montagut Etienne Chief Business Officer | Sale | −14,528 | $81.13 | $1.2M | 73,056 |
| 2023-03-27 | Heino Mary Anne CEO | Option exercise | +44,484 | $19.11 | $850K | 463,881 |
| 2023-03-27 | Heino Mary Anne CEO | Sale | −28,662 | $80.47 | $2.3M | 435,219 |
| 2023-03-27 | Heino Mary Anne CEO | Sale | −15,822 | $81.30 | $1.3M | 419,397 |
| 2023-03-27 | Heino Mary Anne CEO | Option exercise · Stock Option (right to buy) | −44,484 | 0 | ||
| 2023-03-27 | Heino Mary Anne CEO | Option exercise | +44,484 | $19.11 | $850K | 463,881 |
| 2023-03-27 | Heino Mary Anne CEO | Sale | −28,662 | $80.47 | $2.3M | 435,219 |
| 2023-03-27 | Heino Mary Anne CEO | Sale | −15,822 | $81.30 | $1.3M | 419,397 |
| 2023-03-27 | Heino Mary Anne CEO | Option exercise · Stock Option (right to buy) | −44,484 | 0 | ||
| 2023-03-27 | LENO SAM R Director | Option exercise | +7,012 | $19.11 | $134K | 62,937 |
| 2023-03-27 | LENO SAM R Director | Sale | −4,675 | $80.46 | $376K | 58,262 |
Page 15 of 19 · 376 trades